Pluri launches PluriCDMO cell therapy manufacturing division led by Andy Lewin

Pluri Inc.

New CDMO division PluriCDMO offers services from preclinical through commercialization.
Division will be led by Andy Lewin, an experienced CDMO executive.
Mission to deliver high-quality essential therapies; no financial guidance provided.

item 8.01

Pluri Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-001725

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.